- Phase 1 study of combination therapy with L-697,661 and zidovudine. The ACTG 184 Protocol Team. Schooley, R.T., Campbell, T.B., Kuritzkes, D.R., Blaschke, T., Stein, D.S., Rosandich, M.E., Phair, J., Pottage, J.C., Messari, F., Collier, A., Kahn, J. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. (1996)